Usefulness of surveillance imaging in patients with head and neck cancer who are treated with definitive radiotherapy.

ABSTRACT:

Background

The current study was performed to assess the efficacy of surveillance imaging in patients with head and neck cancer (HNC) who are treated definitively with radiotherapy.

Methods

Eligible patients included those with a demonstrable disease-free interval (≥1 follow-up imaging procedure without evidence of disease and a subsequent visit/imaging procedure) who underwent treatment of HNC from 2000 through 2010.

Results

A total of 1508 patients were included. The median overall survival was 99 months, with a median imaging follow-up period of 59 months. Of the 1508 patients, 190 patients (12.6%) experienced disease recurrence (107 patients had locoregional and 83 had distant disease recurrence). A total of 119 patients (62.6%) in the group with disease recurrenc

SUBMITTER: Ng SP 

PROVIDER: S-EPMC7234834 | biostudies-literature | 2019 Jun

REPOSITORIES: biostudies-literature